BSEAsston Pharmaceuticals Ltd· Pharmaceuticals & BiotechnologyHighNeutral
Announced Thu, 2 Jul, 2026 · 18:26 IST

Board approves preferential issue of 24.1 lakh shares at Rs 115

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
—Next day
—
prior close
₹85.00
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-0.1%—
Pharmaceuticals peers, median of 166sector-0.3%—
Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.0
10m
+0.0
15m
+1.2
30m
+2.7
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
—-0.3—+0.2—
Next day
—-0.1—-0.3—
2d
—-0.8—-0.5—
3d
—-2.8—-1.3—
4d
—-1.0—-0.7—
5d
—+0.4—-0.1—
1w
—-0.5—+0.6—
15d
—-1.9—-1.9—
1m
—+0.4—-0.6—
2m
—+3.5—+0.8—
3m
—+2.0—+0.4—
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 166Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board approved issuing up to 24,10,431 equity shares to non-promoters on preferential basis at Rs 115 per share (face value Rs 10, premium Rs 105), raising up to Rs 27.72 crore. Allottees are 14 named individuals and public entities, with Vijay Rathee getting the largest share (13.17 lakh shares, 12.06% post-issue). EGM scheduled for July 31, 2026 for shareholder approval.

Likely market impact

Up to 27.72 crore to be raised from non-promoters at a premium; may dilute existing shareholders by roughly 22 percent on full allotment.